Health ‎Equity

(SLB-060) A Cross-Sectional Study of Race and Ethnicity Reporting and Representation among Cancer Patients in Select US Real-World Data Sources

(B-193) Characterizing Latent Tuberculosis and Screening among Individuals diagnosed with Active Tuberculosis Disease in the United States

(SLB-058) Data Source Selection for Clinical Trial Diversity Planning: Rare Data in Rare Disease

(SLB-059) Leveraging Real-World Data to Support Trial Diversity Action Plans – A Fit-for-Purpose Assessment in Waldenström Macroglobulinemia

(SLB-065) New FDA Guidance On Sex Differences In Post-Marketing Studies: How Much Further Do We Need To Go?

(B-192) Racial and Ethnic Representation in U.S. Based Developmental and Epileptic Encephalopathy Clinical Trials: A Retrospective Analysis

(SLB-061) Racial Disparity in Cardiovascular Outcomes among Older Women with Breast Cancer receiving Anthracycline

(SLB-064) Risk factors associated with post-COVID-19 condition among 810,851 individuals in Sweden: population-based cohort study

(SLB-063) Sex-Related Differences in the Risk of Rehospitalization among Heart Failure Patients in Korea

(SLB-062) Temporal Trends in Racial Differences in Initiation of Medication for Opioid Use Disorder Among Medicaid Beneficiaries